| 1 | Superinfection | 34.5% |
| 2 | Acquired Immunodeficiency Syndrome | 30.8% |
| 3 | AIDS related complex | 30.8% |
| 4 | HIV Seropositivity | 29.2% |
| 5 | HIV Wasting Syndrome | 23.3% |
| 6 | AIDS Dementia Complex | 23.3% |
| 7 | AIDS-Associated Nephropathy | 23.3% |
| 8 | HIV-Associated Lipodystrophy Syndrome | 21% |
| 9 | Simian Acquired Immunodeficiency Syndrome | 16.9% |
| 10 | Rift Valley Fever | 16% |
| 11 | Murine Acquired Immunodeficiency Syndrome | 15.4% |
| 12 | Dengue Fever | 15% |
| 13 | Yellow Fever | 15% |
| 14 | Sexually Transmitted Diseases | 15% |
| 15 | Hemorrhagic Fever, Crimean | 14.9% |
| 16 | Hepatitis E | 14.5% |
| 17 | HTLV-I Infections | 13.2% |
| 18 | Hemorrhagic Fever, American | 13% |
| 19 | Lassa Fever | 13% |
| 20 | Warts | 12.7% |
| 21 | Phlebotomus Fever | 12.7% |
| 22 | Orthomyxoviridae Infections | 12.3% |
| 23 | Picornaviridae Infections | 12.3% |
| 24 | Reoviridae Infections | 12.3% |
| 25 | Arbovirus Infections | 12% |
| 26 | West Nile Fever | 11.8% |
| 27 | Subacute Sclerosing Panencephalitis | 11.1% |
| 28 | Hemorrhagic Fever with Renal Syndrome | 11% |
| 29 | Hepatitis C | 11% |
| 30 | Condylomata Acuminata | 10.7% |
| 31 | Zika Virus Infection | 10.7% |
| 32 | Pelvic Infection | 10.3% |
| 33 | Wound Infection | 10.3% |
| 34 | Soft Tissue Infection | 10.3% |
| 35 | Community-Acquired Infections | 10.3% |
| 36 | Epstein-Barr Virus Infections | 10.2% |
| 37 | Hepatitis, Viral, Human | 10.2% |
| 38 | Viremia | 10.1% |
| 39 | Leukoencephalopathy, Progressive Multifocal | 10.1% |
| 40 | Hepatitis A | 9.3% |
| 41 | Eye Infection | 9% |
| 42 | Respiratory Tract Infections | 9% |
| 43 | Cellulitis | 9% |
| 44 | Hepatitis, Viral, Animal | 8.9% |
| 45 | Hepatitis B | 8.9% |
| 46 | Molluscum Contagiosum | 8.9% |
| 47 | Pneumonia, Viral | 8.9% |
| 48 | Bone Diseases, Infectious | 8.8% |
| 49 | Pregnancy Complications, Infectious | 8.8% |
| 50 | Skin Diseases, Infectious | 8.8% |
| 51 | Arthritis, Infectious | 8.8% |
| 52 | Suppuration | 8.8% |
| 53 | Endotoxemia | 8.7% |
| 54 | Cross Infection | 8.7% |
| 55 | Lymphopenia | 8.7% |
| 56 | Septicemia | 8.7% |
| 57 | Sepsis | 8.7% |
| 58 | Epidermodysplasia Verruciformis | 8.7% |
| 59 | Ulcerative stomatitis | 8.6% |
| 60 | Hidradenitis Suppurativa | 8.3% |
| 61 | Pseudorabies | 8.1% |
| 62 | Cryptosporidiosis | 8% |
| 63 | Chronic Fatigue Syndrome | 8% |
| 64 | Erythema Infectiosum | 7.9% |
| 65 | Mycetoma | 7.9% |
| 66 | Urinary tract infection | 7.7% |
| 67 | Agammaglobulinemia | 7.6% |
| 68 | Dermatomycoses | 7.6% |
| 69 | Skin Diseases, Bacterial | 7.6% |
| 70 | Enterovirus Infections | 7.6% |
| 71 | Flavivirus Infections | 7.6% |
| 72 | Paramyxoviridae Infections | 7.6% |
| 73 | Cardiovirus Infections | 7.6% |
| 74 | Rhabdoviridae Infections | 7.6% |
| 75 | Bacteremia | 7.6% |
| 76 | Herpes Zoster Ophthalmicus | 7.6% |
| 77 | Keratitis, Herpetic | 7.1% |
| 78 | Cytomegalovirus Retinitis | 7.1% |
| 79 | Herpangina | 7.1% |
| 80 | Herpesviridae Infections | 7.1% |
| 81 | Polyomavirus Infections | 7.1% |
| 82 | Exanthema Subitum | 7.1% |
| 83 | Helminthiasis | 7% |
| 84 | Protozoan Infections | 7% |
| 85 | Liver Abscess, Amebic | 7% |
| 86 | Helminthiasis, Animal | 6.9% |
| 87 | Protozoan Infections, Animal | 6.9% |
| 88 | Bacterial Endocarditis | 6.8% |
| 89 | Giardiasis | 6.8% |
| 90 | Babesiosis | 6.7% |
| 91 | Foot-and-Mouth Disease | 6.7% |
| 92 | Fungemia | 6.7% |
| 93 | Hepatitis C, Chronic | 6.6% |
| 94 | Common Cold | 6.6% |
| 95 | Influenza | 6.6% |
| 96 | Catarrh | 6.6% |
| 97 | Pertussis | 6.3% |
| 98 | Candidiasis, Chronic Mucocutaneous | 6.3% |
| 99 | Cutaneous Candidiasis | 6.3% |
| 100 | Eczema Herpeticum | 6.2% |
| 101 | Toxoplasmosis, Cerebral | 6.2% |
| 102 | Parasitic Diseases, Animal | 6.1% |
| 103 | Toxocariasis | 6.1% |
| 104 | Dirofilariasis | 6% |
| 105 | Liver Diseases, Parasitic | 6% |
| 106 | Joint Tuberculosis | 6% |
| 107 | Tuberculosis, Osteoarticular | 6% |
| 108 | Bone Tuberculosis | 6% |
| 109 | Intestinal Diseases, Parasitic | 6% |
| 110 | Pregnancy Complications, Parasitic | 6% |
| 111 | Fascioliasis | 5.9% |
| 112 | Candidemia | 5.9% |
| 113 | Larva Migrans | 5.9% |
| 114 | Leishmaniasis | 5.9% |
| 115 | Erysipelas | 5.9% |
| 116 | Staphylococcal Skin Infections | 5.9% |
| 117 | Parasitemia | 5.9% |
| 118 | Endophthalmitis | 5.8% |
| 119 | Peritonitis | 5.8% |
| 120 | Autoimmune Diseases | 5.8% |
| 121 | Bacterial Infections | 5.8% |
| 122 | Hypersensitivity | 5.8% |
| 123 | Immunoproliferative Disorders | 5.8% |
| 124 | Mycoses | 5.8% |
| 125 | Immune reconstitution syndrome | 5.8% |
| 126 | Immune Reconstitution Inflammatory Syndrome | 5.8% |
| 127 | Osteomyelitis | 5.8% |
| 128 | Periostitis | 5.8% |
| 129 | Surgical Wound Infection | 5.8% |
| 130 | Abscess | 5.8% |
| 131 | Adnexitis | 5.8% |
| 132 | Empyema | 5.8% |
| 133 | Pelvic Inflammatory Disease | 5.8% |
| 134 | Job Syndrome | 5.8% |
| 135 | Panophthalmitis | 5.7% |
| 136 | Erythrasma | 5.7% |
| 137 | HIV Infections | 5.7% |
| 138 | Syphilis | 5.7% |
| 139 | Burkitt Lymphoma | 5.7% |
| 140 | Erythema Chronicum Migrans | 5.6% |
| 141 | Brain Abscess | 5.6% |
| 142 | Genital Herpes | 5.6% |
| 143 | Herpes Labialis | 5.6% |
| 144 | Strongyle Infections, Equine | 5.6% |
| 145 | Hepatitis B, Chronic | 5.5% |
| 146 | Echinococcosis, Hepatic | 5.5% |
| 147 | Chromoblastomycosis | 5.4% |
| 148 | Dermatophytosis | 5.4% |
| 149 | Sporotrichosis | 5.4% |
| 150 | Tinea | 5.4% |
| 151 | Tinea Versicolor | 5.4% |
| 152 | Trichophytosis | 5.4% |
| 153 | Hyalohyphomycosis | 5.4% |
| 154 | Ecthyma | 5.3% |
| 155 | Subacute Bacterial Endocarditis | 5.3% |
| 156 | Coxsackievirus Infections | 5.3% |
| 157 | Rubella | 5.3% |
| 158 | Coronavirus Infections | 5.3% |
| 159 | Nipah Virus Infection | 5.3% |
| 160 | Hydrophobia | 5.3% |
| 161 | Chlamydia Infections | 5.3% |
| 162 | Gonorrhea | 5.3% |
| 163 | Acanthamoeba Keratitis | 5.3% |
| 164 | Impetigo | 5.3% |
| 165 | Blastomycosis | 5.2% |
| 166 | Onchocerciasis | 5.1% |
| 167 | Central Nervous System Bacterial Infections | 5.1% |
| 168 | Corneal Ulcer | 5.1% |
| 169 | Ataxia Telangiectasia | 5.1% |
| 170 | Puerperal Infection | 5.1% |
| 171 | Spondylitis | 5.1% |
| 172 | Psoas Abscess | 5% |
| 173 | Abdominal Abscess | 5% |
| 174 | Appendicitis | 5% |
| 175 | Bacteriuria | 5% |
| 176 | Chronic granulomatous disease | 5% |
| 177 | Pyuria | 5% |
| 178 | Pyomyositis | 5% |
| 179 | Malaria, Cerebral | 5% |
| 180 | Central Nervous System Infection | 5% |
| 181 | Transfusion Reaction | 5% |
| 182 | Hypotensive Transfusion Reaction | 5% |
| 183 | Endotoxic shock | 5% |
| 184 | Septic Shock | 5% |
| 185 | Toxic Shock Syndrome | 5% |
| 186 | Hordeolum | 4.9% |
| 187 | Bacterial conjunctivitis | 4.8% |
| 188 | Cytomegalovirus Infections | 4.8% |
| 189 | Smallpox | 4.8% |
| 190 | Varicella Zoster Virus Infection | 4.8% |
| 191 | Staphylococcal Scalded Skin Syndrome | 4.8% |
| 192 | Porcine Reproductive and Respiratory Syndrome | 4.6% |
| 193 | Leishmaniasis, Cutaneous | 4.6% |
| 194 | Amebiasis | 4.6% |
| 195 | Cestode Infections | 4.6% |
| 196 | Coccidiosis | 4.6% |
| 197 | Malaria | 4.6% |
| 198 | Nematode infections | 4.6% |
| 199 | Acanthamoeba Infection | 4.6% |
| 200 | Retroviridae Infections | 4.6% |
| 201 | Trematode Infections | 4.6% |
| 202 | Trichomonas Infections | 4.6% |
| 203 | Ciliophora Infections | 4.6% |
| 204 | Balamuthia Infection | 4.6% |
| 205 | Arthritis, Reactive | 4.4% |
| 206 | Rhinoscleroma | 4.4% |
| 207 | Neurocysticercosis | 4.4% |
| 208 | Fusariosis | 4.3% |
| 209 | Furunculosis | 4.3% |
| 210 | furuncle | 4.3% |
| 211 | Diverticulitis | 4.3% |
| 212 | Lymphogranuloma Venereum | 4.3% |
| 213 | Glomerulonephritis, Membranoproliferative | 4.3% |
| 214 | carbuncle | 4.2% |
| 215 | Measles | 4.2% |
| 216 | Pleurodynia, Epidemic | 4.2% |
| 217 | Respiratory Syncytial Virus Infections | 4.2% |
| 218 | Vesicular Stomatitis | 4.1% |
| 219 | Tuberculosis, Spinal | 4.1% |
| 220 | Ophthalmia Neonatorum | 3.9% |
| 221 | Trachoma | 3.9% |
| 222 | Infectious Mononucleosis | 3.9% |
| 223 | Tinea Capitis | 3.9% |
| 224 | Onychomycosis | 3.9% |
| 225 | Borrelia Infections | 3.9% |
| 226 | Leptospirosis | 3.9% |
| 227 | Lung Abscess | 3.8% |
| 228 | Opportunistic Infections | 3.8% |
| 229 | Lyme Neuroborreliosis | 3.8% |
| 230 | Autoimmune Lymphoproliferative Syndrome | 3.8% |
| 231 | Diverticulum | 3.8% |
| 232 | Diverticulosis | 3.8% |
| 233 | Discitis | 3.7% |
| 234 | Lyme Disease | 3.7% |
| 235 | Mastoiditis | 3.7% |
| 236 | Relapsing Fever | 3.7% |
| 237 | Petrositis | 3.7% |
| 238 | Chickenpox | 3.6% |
| 239 | Wiskott-Aldrich Syndrome | 3.6% |
| 240 | Gastroenteritis, Transmissible, of Swine | 3.6% |
| 241 | Liver Abscess | 3.6% |
| 242 | Severe Acute Respiratory Syndrome | 3.6% |
| 243 | Mumps | 3.6% |
| 244 | Poliomyelitis | 3.5% |
| 245 | Erythema Induratum | 3.5% |
| 246 | Tinea Pedis | 3.5% |
| 247 | Aspergillosis | 3.4% |
| 248 | Candidiasis | 3.4% |
| 249 | Coccidioidomycosis | 3.4% |
| 250 | Histoplasmosis | 3.4% |
| 251 | Immune Complex Diseases | 3.4% |
| 252 | Paracoccidioidomycosis | 3.4% |
| 253 | Zygomycosis | 3.4% |
| 254 | Antiphospholipid Syndrome | 3.4% |
| 255 | Gram-Negative Bacterial Infections | 3.4% |
| 256 | Gram-Positive Bacterial Infections | 3.4% |
| 257 | Phaeohyphomycosis | 3.4% |
| 258 | Latex allergy | 3.4% |
| 259 | Pneumocystis Infections | 3.4% |
| 260 | Diphyllobothriasis | 3.4% |
| 261 | Echinococcosis | 3.4% |
| 262 | Entamoebiasis | 3.4% |
| 263 | Hymenolepiasis | 3.4% |
| 264 | Malaria, Falciparum | 3.4% |
| 265 | Malaria, Vivax | 3.4% |
| 266 | Mite Infestations | 3.4% |
| 267 | Myiasis | 3.4% |
| 268 | Opisthorchiasis | 3.4% |
| 269 | Schistosomiasis | 3.4% |
| 270 | Tick Infestations | 3.4% |
| 271 | Toxoplasmosis | 3.4% |
| 272 | Trypanosomiasis | 3.4% |
| 273 | Secernentea Infections | 3.4% |
| 274 | Isosporiasis | 3.4% |
| 275 | Thrombocytopenic purpura | 3.4% |
| 276 | Neuroaspergillosis | 3.4% |
| 277 | Retropharyngeal Abscess | 3.4% |
| 278 | Epidural Abscess | 3.3% |
| 279 | Autoimmune thrombocytopenia | 3.3% |
| 280 | Immune thrombocytopenic purpura | 3.3% |
| 281 | Neurosyphilis | 3.3% |
| 282 | Peritonsillar Abscess | 3.3% |
| 283 | Bell Palsy | 3.2% |
| 284 | AIDS-Related Opportunistic Infections | 3.1% |
| 285 | Environmental Illness | 3% |
| 286 | Primary amyloidosis | 3% |
| 287 | Monoclonal Gammopathy of Undetermined Significance | 3% |
| 288 | Lupus Erythematosus, Systemic | 2.9% |
| 289 | Lymphoproliferative Disorders | 2.9% |
| 290 | Otomycosis | 2.9% |
| 291 | Overlap syndrome | 2.9% |
| 292 | Invasive Pulmonary Aspergillosis | 2.9% |
| 293 | Addison Disease | 2.9% |
| 294 | Paraproteinemias | 2.9% |
| 295 | Pemphigus | 2.9% |
| 296 | Piedra | 2.9% |
| 297 | Central Nervous System Fungal Infections | 2.9% |
| 298 | Autoimmune thyroiditis | 2.9% |
| 299 | Primary Adrenal Insufficiency | 2.9% |
| 300 | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 2.9% |
| 301 | Autoimmune hepatitis | 2.9% |
| 302 | Bacterial Vaginosis | 2.9% |
| 303 | Lice Infestations | 2.9% |
| 304 | Trichomonas Vaginitis | 2.9% |
| 305 | Human Ehrlichiosis | 2.9% |
| 306 | Blackwater Fever | 2.8% |
| 307 | Cysticercosis | 2.8% |
| 308 | Hypodermyiasis | 2.8% |
| 309 | Leishmaniasis, Visceral | 2.8% |
| 310 | Schistosomiasis japonica | 2.8% |
| 311 | Schistosomiasis mansoni | 2.8% |
| 312 | Sparganosis | 2.8% |
| 313 | African Trypanosomiasis | 2.8% |
| 314 | Chagas Disease | 2.8% |
| 315 | Ascaridida Infections | 2.8% |
| 316 | Oxyurida Infections | 2.8% |
| 317 | Asthma, Aspirin-Induced | 2.7% |
| 318 | Japanese Spotted Fever | 2.6% |
| 319 | Lung Diseases, Fungal | 2.6% |
| 320 | Serum Sickness | 2.6% |
| 321 | Meningitis, Cryptococcal | 2.6% |
| 322 | Hypergammaglobulinemia | 2.6% |
| 323 | Human anaplasmosis | 2.6% |
| 324 | Latent Autoimmune Diabetes in Adults | 2.6% |
| 325 | Pneumonia, Bacterial | 2.5% |
| 326 | Dermatitis Herpetiformis | 2.5% |
| 327 | Kounis Syndrome | 2.5% |
| 328 | Transfusion-Related Acute Lung Injury | 2.5% |
| 329 | Ascariasis | 2.5% |
| 330 | Filariasis | 2.5% |
| 331 | Gnathostomiasis | 2.5% |
| 332 | Hookworm Infections | 2.5% |
| 333 | Oxyuriasis | 2.5% |
| 334 | Strongyloidiasis | 2.5% |
| 335 | Trichinellosis | 2.5% |
| 336 | Trichostrongyloidiasis | 2.5% |
| 337 | Multiple Myeloma | 2.4% |
| 338 | Loiasis | 2.4% |
| 339 | Enterobiasis | 2.4% |
| 340 | Rheumatoid Arthritis | 2.3% |
| 341 | Juvenile arthritis | 2.3% |
| 342 | Graves Disease | 2.3% |
| 343 | Rocky Mountain Spotted Fever | 2.3% |
| 344 | Actinomycetales Infections | 2.3% |
| 345 | anaphylaxis | 2.3% |
| 346 | Bordetella Infections | 2.3% |
| 347 | Brucellosis | 2.3% |
| 348 | Campylobacter infection | 2.3% |
| 349 | Clostridium Infections | 2.3% |
| 350 | Enterobacteriaceae Infections | 2.3% |
| 351 | Food Allergy | 2.3% |
| 352 | Listeriosis | 2.3% |
| 353 | Mucormycosis | 2.3% |
| 354 | Pseudomonas Infections | 2.3% |
| 355 | Q Fever | 2.3% |
| 356 | Staphylococcal Infections | 2.3% |
| 357 | Streptococcal Infections | 2.3% |
| 358 | Vibrio Infections | 2.3% |
| 359 | Helicobacter Infections | 2.3% |
| 360 | Bacillaceae Infections | 2.3% |
| 361 | Neisseriaceae Infections | 2.3% |
| 362 | Burkholderia Infections | 2.3% |
| 363 | Clostridium difficile infection | 2.3% |
| 364 | Flavobacteriaceae Infections | 2.3% |
| 365 | Moraxellaceae Infections | 2.3% |
| 366 | Burkholderia cepacia Infection | 2.3% |
| 367 | Anaphylactic shock | 2.3% |
| 368 | Anti-Glomerular Basement Membrane Disease | 2.2% |
| 369 | Meningitis, Listeria | 2.2% |
| 370 | Chagas Cardiomyopathy | 2.2% |
| 371 | Toxoplasmosis, Congenital | 2.1% |
| 372 | Syphilis, Congenital | 2.1% |
| 373 | Herpes Zoster Oticus | 2.1% |
| 374 | Sezary Syndrome | 2% |
| 375 | Meningitis, Haemophilus | 2% |
| 376 | Meningitis, Pneumococcal | 2% |
| 377 | Aspergillosis, Allergic Bronchopulmonary | 2% |
| 378 | Erysipelothrix infection | 2% |
| 379 | Respiratory Hypersensitivity | 2% |
| 380 | Oral candidiasis | 1.9% |
| 381 | Sick Building Syndrome | 1.9% |
| 382 | Multiple Chemical Sensitivity | 1.9% |
| 383 | Plasmacytoma | 1.9% |
| 384 | Tumor Lysis Syndrome | 1.9% |
| 385 | Urticaria | 1.9% |
| 386 | Vasculitis, Leukocytoclastic, Cutaneous | 1.9% |
| 387 | Pulmonary Aspergillosis | 1.9% |
| 388 | Bronchopulmonary Aspergillosis | 1.9% |
| 389 | Kernicterus | 1.8% |
| 390 | Myasthenia Gravis, Autoimmune, Experimental | 1.8% |
| 391 | Lymphoma | 1.7% |
| 392 | Myasthenia Gravis | 1.7% |
| 393 | Uveomeningoencephalitic Syndrome | 1.7% |
| 394 | Mastocytosis | 1.7% |
| 395 | Drug Eruptions | 1.7% |
| 396 | Tuberculosis, Meningeal | 1.7% |
| 397 | Acinetobacter Infections | 1.7% |
| 398 | Actinomycosis | 1.7% |
| 399 | Bacteroides Infections | 1.7% |
| 400 | Cholera | 1.7% |
| 401 | Corynebacterium Infections | 1.7% |
| 402 | Escherichia coli Infections | 1.7% |
| 403 | Gas Gangrene | 1.7% |
| 404 | Haemophilus Infections | 1.7% |
| 405 | Klebsiella Infections | 1.7% |
| 406 | Meningococcal Infections | 1.7% |
| 407 | Mycobacterium Infections | 1.7% |
| 408 | Mycoplasma Infections | 1.7% |
| 409 | Nocardia Infections | 1.7% |
| 410 | Pasteurella Infections | 1.7% |
| 411 | Pneumococcal Infections | 1.7% |
| 412 | Proteus Infections | 1.7% |
| 413 | Rickettsia Infections | 1.7% |
| 414 | Salmonella infections | 1.7% |
| 415 | Scarlet Fever | 1.7% |
| 416 | Scrub Typhus | 1.7% |
| 417 | Tetanus | 1.7% |
| 418 | Milk Allergy | 1.7% |
| 419 | Serratia Infections | 1.7% |
| 420 | Ureaplasma Infections | 1.7% |
| 421 | Pulmonary Nocardiosis | 1.7% |
| 422 | Schnitzler Syndrome | 1.7% |
| 423 | Wheat Hypersensitivity | 1.7% |
| 424 | Heavy Chain Disease | 1.7% |
| 425 | Meningitis, Bacterial | 1.7% |
| 426 | Meningitis, Fungal | 1.7% |
| 427 | Granulomatosis with polyangiitis | 1.7% |
| 428 | Dermatitis, Allergic Contact | 1.7% |
| 429 | Hydrops Fetalis | 1.7% |
| 430 | Candidiasis, Vulvovaginal | 1.7% |
| 431 | Stiff-Person Syndrome | 1.5% |
| 432 | Polyradiculoneuropathy | 1.5% |
| 433 | Polyradiculoneuritis | 1.5% |
| 434 | Cryoglobulinemia | 1.5% |
| 435 | Felty Syndrome | 1.5% |
| 436 | POEMS Syndrome | 1.5% |
| 437 | Lupus Nephritis | 1.5% |
| 438 | Lupus Vasculitis, Central Nervous System | 1.4% |
| 439 | Mastocytosis, Systemic | 1.4% |
| 440 | Neuromyelitis Optica | 1.4% |
| 441 | Diphtheria | 1.4% |
| 442 | Leprosy | 1.4% |
| 443 | Mycobacterium Infections, Nontuberculous | 1.4% |
| 444 | Psittacosis | 1.4% |
| 445 | Paratyphoid Fever | 1.4% |
| 446 | Plague | 1.4% |
| 447 | Tuberculosis | 1.4% |
| 448 | Typhoid Fever | 1.4% |
| 449 | TYPHUS | 1.4% |
| 450 | Yersinia pseudotuberculosis Infections | 1.4% |
| 451 | Bubonic Plague | 1.4% |
| 452 | Mycobacterium abscessus Infection | 1.4% |
| 453 | Leukoencephalitis, Acute Hemorrhagic | 1.4% |
| 454 | Vasculitis, Central Nervous System | 1.3% |
| 455 | Dermatitis, Atopic | 1.3% |
| 456 | Rheumatoid Vasculitis | 1.3% |
| 457 | Rheumatic Fever | 1.3% |
| 458 | Angioedema | 1.3% |
| 459 | Multiple Sclerosis | 1.3% |
| 460 | Mycobacterium avium-intracellulare Infection | 1.3% |
| 461 | Lymph Node Tuberculosis | 1.3% |
| 462 | Tuberculosis, Miliary | 1.3% |
| 463 | Tuberculosis, Multidrug-Resistant | 1.3% |
| 464 | Leprosy, Multibacillary | 1.3% |
| 465 | Latent Tuberculosis | 1.3% |
| 466 | Hodgkin Disease | 1.3% |
| 467 | Leukemia, Plasma Cell | 1.3% |
| 468 | Lymphoma, Non-Hodgkin | 1.3% |
| 469 | Enterocolitis, Pseudomembranous | 1.2% |
| 470 | Leukemia, T-Cell | 1.2% |
| 471 | Acute Generalized Exanthematous Pustulosis | 1.2% |
| 472 | pseudomembranous colitis | 1.2% |
| 473 | Dysentery, Bacillary | 1.2% |
| 474 | Leukemia, B-Cell | 1.2% |
| 475 | Salmonella Infections, Animal | 1.2% |
| 476 | Lambert-Eaton Myasthenic Syndrome | 1.2% |
| 477 | Waldenstrom Macroglobulinemia | 1.2% |
| 478 | Sicca Syndrome | 1.2% |
| 479 | Sjogren's Syndrome | 1.2% |
| 480 | Rheumatic Heart Disease | 1.2% |
| 481 | Salmonella food poisoning | 1.2% |
| 482 | Borderline leprosy | 1.2% |
| 483 | Leprosy, Lepromatous | 1.2% |
| 484 | Tuberculoid leprosy | 1.2% |
| 485 | Extensively Drug-Resistant Tuberculosis | 1.2% |
| 486 | Asthma | 1.1% |
| 487 | Botulism | 1.1% |
| 488 | Composite Lymphoma | 1.1% |
| 489 | Waterhouse-Friderichsen Syndrome | 1.1% |
| 490 | Encephalomyelitis, Acute Disseminated | 1.1% |
| 491 | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1.1% |
| 492 | Erythema Nodosum | 1.1% |
| 493 | Neuritis, Autoimmune, Experimental | 1.1% |
| 494 | Dermatitis, Photoallergic | 1.1% |
| 495 | Lymphangioleiomyomatosis | 1.1% |
| 496 | Tuberculosis, Gastrointestinal | 1.1% |
| 497 | Tuberculosis, Central Nervous System | 1.1% |
| 498 | Asthma, Exercise-Induced | 1% |
| 499 | Status Asthmaticus | 1% |
| 500 | Multiple Sclerosis, Chronic Progressive | 1% |
| 501 | Multiple Sclerosis, Relapsing-Remitting | 1% |
| 502 | Lymphoma, Follicular | 1% |
| 503 | T-Cell Lymphoma | 1% |
| 504 | Mantle cell lymphoma | 1% |
| 505 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1% |
| 506 | Leukemia, Large Granular Lymphocytic | 1% |
| 507 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1% |
| 508 | Guillain-Barre Syndrome | 1% |
| 509 | Tuberculosis, Pulmonary | 1% |
| 510 | Asthma, Occupational | 1% |
| 511 | Farmer's Lung | 0.9% |
| 512 | Angioedemas, Hereditary | 0.9% |
| 513 | Hereditary Angioedema Type III | 0.9% |
| 514 | Hereditary Angioedema Types I and II | 0.9% |
| 515 | Lymphoma, T-Cell, Cutaneous | 0.9% |
| 516 | Lymphoma, AIDS-Related | 0.9% |
| 517 | Enteropathy-Associated T-Cell Lymphoma | 0.9% |
| 518 | Primary Effusion Lymphoma | 0.9% |
| 519 | Hay fever | 0.9% |
| 520 | Rhinitis, Allergic, Perennial | 0.9% |
| 521 | Toxic Epidermal Necrolysis | 0.9% |
| 522 | Stevens-Johnson Syndrome | 0.9% |
| 523 | Mycosis Fungoides | 0.9% |
| 524 | Lymphomatoid Papulosis | 0.9% |
| 525 | Plasmablastic lymphoma | 0.9% |
| 526 | Lymphomatoid Granulomatosis | 0.8% |
| 527 | Giant Cell Arteritis | 0.8% |
| 528 | Temporal Arteritis | 0.8% |
| 529 | Myelitis, Transverse | 0.8% |
| 530 | Lemierre Syndrome | 0.8% |
| 531 | Tuberculosis, Renal | 0.7% |
| 532 | Miller Fisher Syndrome | 0.6% |
